AgeneBio develops innovative therapeutics that prevent neurodegeneration and preserves cognitive function.

Baltimore, MD
Joined October 2014
This JHU startup is working on a treatment to prevent Alzheimer’s bltmo.re/QNJ1A
3
2
Baltimore Sun - Hopkins, AgeneBio to launch trial of Alzheimer's drug in partnership with NIH ow.ly/34a7Lm
1
3
.@agenebio CEO Jerry McLaughlin discusses the promise of a different approach to Alzheimer's on The Bio Report soundcloud.com/levine-media-…
.@agenebio CEO Jerry McLaughlin discusses the promise of a different approach to Alzheimer's on The Bio Report buff.ly/1JUtTXs
AgeneBio retweeted
Agenebio’s AGB101 improves memory in phase II aMCI trial; phase III test up next
1
1
1
AgeneBio scouts deals and dollars ahead of #Alzheimers PhIII - fiercebiotech.com/story/agen… by @JohnCFierce